Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages.

PubWeight™: 1.06‹?› | Rank: Top 10%

🔗 View Article (PMID 9887201)

Published in Am J Physiol on January 01, 1999

Authors

C A Louis1, V Mody, W L Henry, J S Reichner, J E Albina

Author Affiliations

1: Department of Surgery, Division of Surgical Research, Rhode Island Hospital and Brown University School of Medicine, Providence, Rhode Island 02903, USA.

Articles citing this

Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol (2009) 2.59

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation (2006) 2.23

Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy. J Immunol (2006) 1.94

Macrophage phenotypes during tissue repair. J Leukoc Biol (2013) 1.67

Retracted The absence of MyD88 has no effect on the induction of alternatively activated macrophage during Fasciola hepatica infection. BMC Immunol (2011) 1.40

Selenium levels affect the IL-4-induced expression of alternative activation markers in murine macrophages. J Nutr (2011) 0.94

Arginine and citrulline and the immune response in sepsis. Nutrients (2015) 0.93

Macrophage activation and skeletal muscle healing following traumatic injury. J Pathol (2014) 0.91

Differential macrophage activation alters the expression profile of NTPDase and ecto-5'-nucleotidase. PLoS One (2012) 0.90

Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.88

Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I. Int J Parasitol (2011) 0.88

rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition. J Transl Med (2003) 0.87

Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation. J Ethnopharmacol (2008) 0.87

Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions. Am J Pathol (2011) 0.85

Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures. J Neuroinflammation (2009) 0.83

Immunization with a neural-derived peptide protects the spinal cord from apoptosis after traumatic injury. Biomed Res Int (2013) 0.83

Editorial: Orchestration of macrophage polarization by polyamines. J Leukoc Biol (2012) 0.77

Articles by these authors

Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation (1980) 3.87

Echocardiographic measurements in normal subjects from infancy to old age. Circulation (1980) 3.55

Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation (1973) 3.31

Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med (1993) 2.98

The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med (1979) 2.86

Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol (1993) 2.59

Comparative left ventricular dimensions in trained athletes. Ann Intern Med (1975) 2.27

Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J Immunol (1991) 2.20

Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation (1976) 2.08

Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol (1990) 2.06

Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood. Circulation (1978) 2.05

Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.96

Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation (1975) 1.96

The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88

Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85

Arginine metabolism in wounds. Am J Physiol (1988) 1.81

Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol (1987) 1.78

Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res (1994) 1.66

HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol (2001) 1.61

Asymetric septal hypertrophy in childhood. Circulation (1976) 1.56

Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course. Circulation (1973) 1.55

Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.52

Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol (1989) 1.50

Regulation of macrophage functions by L-arginine. J Exp Med (1989) 1.49

Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography. Circulation (1975) 1.49

Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease. J Clin Ultrasound (1979) 1.46

Use of retinol-binding protein and prealbumin as indicators of the response to nutrition therapy. J Am Diet Assoc (1989) 1.44

Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation (1979) 1.42

Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation (1977) 1.41

Macrophage-induced neutrophil apoptosis. J Immunol (2000) 1.35

Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am J Physiol (1998) 1.32

Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). Am J Cardiol (1975) 1.31

Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients. Circulation (1980) 1.22

Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22

Evaluation of the ability of echocardiography to measure acute alterations in left ventricular volume. Circulation (1974) 1.21

Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography. Am J Cardiol (1978) 1.17

Asymmetric septal hypertrophy (ASH) in infancy. Circulation (1974) 1.15

A simple Doppler echocardiographic method for estimating severity of aortic regurgitation. Am J Cardiol (1986) 1.14

Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med (1980) 1.14

Identification of congenital malformations of the great arteries in infants by real-time two-dimensional echocardiography. Circulation (1975) 1.14

Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway. J Immunol (1989) 1.13

Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart diseases: echocardiographic and morphologic findings. Circulation (1977) 1.12

Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation (1978) 1.12

Malaria infection in transplant recipient. J Natl Med Assoc (1978) 1.11

Doppler color flow "proximal isovelocity surface area" method for estimating volume flow rate: effects of orifice shape and machine factors. J Am Coll Cardiol (1991) 1.11

Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J Surg Res (1991) 1.10

Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation (1980) 1.10

Tunnel subaortic stenosis: left ventricular outflow tract obstruction produced by fibromuscular tubular narrowing. Circulation (1976) 1.10

Evaluation of blood flow velocity in the ascending aorta and main pulmonary artery of normal subjects by Doppler echocardiography. Am Heart J (1984) 1.09

Echocardiographic observations in patients with systemic infiltrative disease involving the heart. Am J Cardiol (1977) 1.09

Macrophage phagocytosis of wound neutrophils. J Leukoc Biol (1999) 1.09

Interleukin-6 activity in wounds. Am J Physiol (1994) 1.06

Reproducibility of Doppler aortic blood flow measurements: studies on intraobserver, interobserver and day-to-day variability in normal subjects. Am J Cardiol (1984) 1.05

Effects of self-induced starvation on cardiac size and function in anorexia nervosa. Circulation (1978) 1.04

Macrophage activation by culture in an anoxic environment. J Immunol (1995) 1.03

Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med (1978) 1.03

Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter. Am Heart J (1990) 1.03

The use of Doppler flow velocity measurement to assess the hemodynamic response to vasodilators in patients with heart failure. Circulation (1983) 1.02

Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Echocardiographic and gross anatomic findings. Circulation (1974) 1.02

Left ventricular outflow tract obstruction due to systolic anterior motion of the anterior mitral leaflet in patients with concentric left ventricular hypertrophy. Circulation (1978) 1.02

Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro. Circulation (1989) 1.01

Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol (1981) 1.00

Pulsed Doppler echocardiographic study of left ventricular filling in dilated cardiomyopathy. Am J Cardiol (1986) 0.99

Determinants of ventricular septal motion. Influence of relative right and left ventricular size. Circulation (1976) 0.98

Superiority of two-dimensional measurement of aortic vessel diameter in Doppler echocardiographic estimates of left ventricular stroke volume. J Am Coll Cardiol (1985) 0.98

Congenital heart malformations associated with disproportionate ventricular septal thickening. Circulation (1975) 0.97

Computer analysis of cardiac catheterization data. Am J Cardiol (1968) 0.97

A pulsed Doppler echocardiographic study of the postnatal changes in pulmonary artery and ascending aortic flow in normal term newborn infants. Am Heart J (1987) 0.96

Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins. J Immunol (1999) 0.96

TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells. Loss Of response in tumor cells. J Biol Chem (2000) 0.95

Toxicity of ultraviolet radiation exposure to the lens expressed by maximum tolerable dose. Dev Ophthalmol (2002) 0.95

Molecular and metabolic evidence for the restricted expression of inducible nitric oxide synthase in healing wounds. Am J Pathol (1999) 0.95

A sector scanner for real time two-dimensional echocardiography. Circulation (1974) 0.95

Non-invasive measurement of cardiac output by a single breath constant expiratory technique. Thorax (1984) 0.93

Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev (1998) 0.93

Nitric oxide in inflammation and immunity. New Horiz (1995) 0.93

Left ventricular filling in hypertrophic cardiomyopathy: a pulsed Doppler echocardiographic study. J Am Coll Cardiol (1986) 0.93

Preoperative exercise capacity in symptomatic patients with aortic regurgitation as a predictor of postoperative left ventricular function and long-term prognosis. Circulation (1980) 0.93

Trauma-hemorrhage delays wound healing potentially by increasing pro-inflammatory cytokines at the wound site. Surgery (1999) 0.91

Echocardiographic comparison of black and white hypertensive subjects. J Natl Med Assoc (1979) 0.90

Relationship between age, body size, gender, and blood pressure and Doppler flow measurements in the aorta and pulmonary artery. Am Heart J (1987) 0.90

Evaluation of aortic valve replacement in patients with valvular aortic stenosis. Circulation (1980) 0.89

Delayed cardiac tamponade associated with prophylactic anticoagulation in patients undergoing coronary bypass grafting. Early diagnosis with two-dimensional echocardiography. J Thorac Cardiovasc Surg (1978) 0.89

Videodensitometric determination of minimum coronary artery luminal diameter before and after angioplasty. Am J Cardiol (1987) 0.89

Glycosyltransferase probes. Methods Enzymol (1989) 0.89

Impact of nitric oxide on macrophage glucose metabolism and glyceraldehyde-3-phosphate dehydrogenase activity. Am J Physiol (1995) 0.89

Effects of lambda-carrageenan induced experimental enterocolitis on splenocyte function and nitric oxide production. J Surg Res (1996) 0.88

Receptor-mediated phagocytosis of rat macrophages is regulated differentially for opsonized particles and non-opsonized particles containing beta-glucan. Immunology (2001) 0.88

Predictive versus measured energy expenditure using limits-of-agreement analysis in hospitalized, obese patients. JPEN J Parenter Enteral Nutr (1999) 0.87